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Abstract 
Background: Auditory and vestibular disorders are prevalent sensory disabilities caused by genetic and environmen‑
tal (noise, trauma, chemicals) factors that often damage mechanosensory hair cells of the inner ear. Development of 
treatments for inner ear disorders of hearing and balance relies on the use of animal models such as fish, amphibians, 
reptiles, birds, and non‑human mammals. Here, we aimed to augment the utility of the genus Xenopus for uncovering 
genetic mechanisms essential for the maintenance of inner ear structure and function.
Results: Using Affymetrix GeneChip® X. laevis Genome 2.0 Arrays and Illumina‑Solexa sequencing methods, we deter‑
mined that the transcriptional profile of the Xenopus laevis inner ear comprises hundreds of genes that are ortholo‑
gous to OMIM® genes implicated in deafness and vestibular disorders in humans. Analysis of genes that mapped to 
both technologies demonstrated that, with our methods, a combination of microarray and RNA‑Seq detected expres‑
sion of more genes than either platform alone.
Conclusions: As part of this study we identified candidate scaffold regions of the Xenopus tropicalis genome that can 
be used to investigate hearing and balance using genetic and informatics procedures that are available through the 
National Xenopus Resource (NXR), and the open access data repository, Xenbase. The results and approaches pre‑
sented here expand the viability of Xenopus as an animal model for inner ear research.
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Background
The vertebrate inner ear serves a unique dual function as 
a receptor for the senses of hearing and balance. The inner 
ear’s ability to detect sound and maintain spatial orienta-
tion is vital to the survival of an organism. In humans and 
other vertebrates, disorders of hearing and balance can 
lead to disabilities that can reduce the lifespan, and in the 
case of humans, severely compromise the quality of life. It 
is estimated that approximately 1 in 20 Americans are hard 
of hearing or are functionally deaf, and that 35 % of adults 
ages 40 and older (69 million Americans) have experienced 
vestibular dysfunction during some period in their lives [1, 
2]. Vestibular and auditory disorders are frequently caused 
by damage to the mechanosensory hair cells of the inner 
ear or to the afferent and efferent neurons of the eighth 
cranial nerve [2, 3]. The number of affected individu-
als who experience difficulties with hearing or balance is 
expected to increase as the population ages [2]. In order 
to address this growing global health challenge, it is crucial 
to understand the mechanisms that underlie the senses of 
hearing and balance, and especially to identify the genetic 
basis of acoustic-vestibular health and dysfunction [3, 4].
Human inner ears are typically not a feasible choice for 
genetic studies due to the invasive nature of the technical 
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approaches, and the frequent need to terminate animal 
life as part of the experimental design. Consequently, 
non-human animal models are the foundation for acous-
tico-vestibular research [5, 6]. When choosing an organ-
ism to study the mechanisms of hearing and balance 
with the goal of addressing human health, it is advisable 
to select an organism whose inner ear resembles that of 
humans. The amphibian inner ear is similar to the human 
inner ear, with the notable exception that sound recep-
tion is distributed among three sensory organs instead of 
the solitary cochlea [7–9]. Like humans, and many other 
mammals, amphibians are capable of vocal communica-
tion. However, unlike mammals, amphibians can regen-
erate damaged hair cells and their sensory epithelia have 
the capacity for the perpetual production of new hair 
cells throughout animal life [5, 6]. These characteristics 
confer an additional benefit to the use of animals from 
this class for research that aims to discover mechanisms 
that can restore function to damaged inner ears.
Xenopus, the African clawed frog, is an amphibian 
native to Sub-Saharan Africa that has become an increas-
ingly popular subject for inner ear investigations over 
the past decade, especially for research that addresses 
embryonic placode and larval organ formation [7, 10, 11]. 
The genus Xenopus comprises about 15 species of frogs; 
the two most common research species are Xenopus lae-
vis and Xenopus tropicalis both of which have long been 
used in medical and scientific investigations [12]. An 
established model for developmental studies of embryo-
genesis, Xenopus’ contributions to medicine date to the 
1930s, when pregnancy was confirmed by the induction 
of ovulation in female Xenopus injected with the urine 
of human females [13]. Almost a century of research 
has shown conservation of cellular, developmental, and 
genomic organization between Xenopus and mammals, 
and established its utility for investigations of organ and 
tissue repair due to Xenopus’ documented regenerative 
capacity [14, 15].
Understanding of the genetic underpinnings of hear-
ing and balance common to Xenopus and humans can be 
furthered by using high throughput approaches to profile 
the cadre of genes whose collective expression is required 
in a functioning inner ear organ [16, 17]. To this end we 
used bioinformatics tools, in combination with microar-
rays and RNA-Seq, to determine whether Online Men-
delian Inheritance in Man® (OMIM®) orthologues for 
hearing and balance are expressed in the Xenopus inner 
ear. Our experimental approach also was designed to 
permit comparison of the capacity of these two technolo-
gies to detect candidate OMIM® orthologues in Xenopus 
transcriptomes.
We began by mining the OMIM® database to assem-
ble a list of OMIM® genes associated with both deafness 
and vestibular disorders, with deafness, or with vestibu-
lar disorders. Informatics and curation approaches were 
used to identify candidate orthologues to OMIM® deaf-
ness and vestibular disorder genes among the Xenopus 
laevis Probe Set Identifiers (Xl-PSIDs) on the Affymetrix 
Genechip® X. laevis Genome 2.0 Array, and among the 
scaffolds of the X. tropicalis Genome Assembly v.2. Gene 
expression was evaluated for candidate OMIM® ortho-
logues that met threshold criteria established for the two 
technologies. Our results suggest that orthologues for 259 
(74 %) of the human OMIM® genes associated with audi-
tory and vestibular function are expressed in the Xenopus 
inner ear at the animal age examined in this study. When 
we undertook a detailed expression analysis of the 190 
OMIM® deafness and vestibular disorder genes that could 
be mapped to both the Xl-PSIDs on the microarray and 
X. tropicalis genome scaffolds, we found that a combina-
tion of both approaches uncovered expression of more 
candidate OMIM® orthologues than either method alone. 
Taken together, the results and the approaches presented 
here enhance the relevance of the genus Xenopus for inves-
tigations of the sensory systems for hearing and balance.
Methods
Inner ear RNA
Larval Xenopus laevis stages 56–58 with fully formed 
inner ears [7, 10, 18] were obtained from Nasco (Fort 
Atkinson, WI, USA). Specimens were euthanized in a 2 % 
solution of ethyl 3-aminobenzoate methanesulfonate salt 
before aseptic removal of the inner ear tissue. Protocols 
were approved by the Institutional Animal Care and Use 
Committee (IACUC) of New Mexico State University.
Biological samples for microarray and RNA-Seq analy-
sis comprised 16–20 inner ears (8–10 animals) per RNA 
sample (3 for microarray; 1 for RNA seq). Inner ear 
RNA was isolated with the Qiagen® RNeasy® Mini Kit 
according to established procedures [19]. RNA quality 
was assessed using the Agilent 2100 Bioanalyzer. Experi-
mental samples with a minimum RNA integrity num-
ber (RIN) of 9.0 were shipped to the National Center 
for Genome Resources, (NCGR; Santa Fe, NM, USA) 
for Illumina-Solexa sequencing or to the Massachusetts 
Institute of Technology (MIT; Cambridge, MA, USA) 
BioMicro Center for microarray analysis with the Affym-
etrix GeneChip® X. laevis Genome 2.0 Array.
Profiling inner ear RNA with Illumina‑Solexa sequencing 
and Affymetrix GeneChip® Xenopus laevis Genome 2.0 
Array
RNA-sequencing was completed using the Illumina-
Solexa platform for sequencing by synthesis. As recom-
mended by the manufacturer, short-insert paired end 
(SIPE) libraries were prepared from total RNA according 
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to Illumina’s mRNA-Seq Sample Prep Protocol v2.0 
(Illumina, San Diego, CA, USA). The resultant double-
stranded cDNA concentration was measured on a Nan-
oDrop spectrophotometer, and size and purity were 
determined on the 2100 Bioanalyzer using a DNA 1000 
Nano kit. The cDNA libraries were cluster amplified on 
Illumina flowcells, sequenced on the GAII Sequencer as 
36-cycle single-end reads, and processed using Illumina 
software v1.0. The RNA sample produced 28,764,261 Illu-
mina reads with an average quality score above Q30. The 
reads were aligned to the X. tropicalis genome (UCSC 
XenTro3; JGI 4.1) using the algorithm for genomic map-
ping and alignment program (GMAP) and Alpheus® 
Sequence Variant Detection System v3.1 [20]. The GMAP 
program was used by Alpheus® to align high quality 
reads containing bases with a PHRED score ≥20 with 
default parameter settings, except base pair mismatches 
was set to 2 (based on read length). Alpheus® was used 
to normalize reads per million (RPM). The total number 
of reads mapped to each of the OMIM® genes were log2 
transformed. Fifty-one percent of reads aligned to the X. 
tropicalis reference genome. The microarray procedures 
and data were processed as previously described [17]. 
Data from three biological replicates were preprocessed 
using Gene Chip robust multichip averaging (GCRMA) 
to generate a log2 transformed intensity measure for each 
Xl-PSID.
The original data analyzed in this publication have 
been deposited in NCBI’s Gene Expression Omnibus and 
are accessible through GEO Series accession numbers 
GSE69701 (RNA-Seq) and GSE73829 (microarray).
Identification of OMIM deafness and vestibular disorder 
genes
The OMIM® database was regularly accessed and manu-
ally inspected (most recently, May 2015) to identify a list 
of 299 HUGO Gene Nomenclature Committee (HGNC) 
symbols pertaining to deafness by using the query term 
“deafness” and limiting the results to known sequences 
and phenotypes to search for syndromic and non-syn-
dromic deafness genes in humans [21]. Using the same 
criteria described above, but using the query term “ves-
tibular”, a list of 123 HGNC symbols was obtained for 
genes associated with vestibular disorders [21]. The 
OMIM® deafness and vestibular disorder genes sym-
bols were analyzed to determine genes uniquely associ-
ated with deafness only, vestibular disorder only or dual 
phenotype (deafness and vestibular disorders). Human 
protein sequences were obtained for 279 of the 299 deaf-
ness HGNC symbols and 120 of the 123 vestibular dis-
order HGNC symbols as described in Powers et al. [17]. 
Genes uniquely associated with deafness, vestibular dis-
orders, or dual phenotype (deafness and vestibular disor-
ders) were identified by comparing the deafness OMIM 
gene list with the vestibular disorder OMIM® gene list 
(Table 1; Additional file 1).
Analysis of OMIM® deafness and vestibular disorder 
orthologous genes in the Xenopus inner ear transcriptome
Figure  1 summarizes the approach used to determine 
expression of OMIM® orthologues in RNA-Seq and 
microarray data. Human protein sequences correspond-
ing to the HGNC symbols were retrieved from the 
Ensembl website (release 79). Standalone BLAST was 
used to map the human protein sequences to the X. lae-
vis Affymetrix consensus sequences (provided by the 
manufacturer) and the X. tropicalis predicted proteins. 
The consensus sequences (15,491) were downloaded 
directly from Affymetrix; predicted protein sequences 
(27,916) were downloaded from the Joint Genome Insti-
tute (JGI) genome portal. The scaffold number and coor-
dinates for each of the OMIM® genes were also acquired 
from the JGI genome portal. For RNA-Seq, the BLASTP 
alignments of the Ensembl human protein sequences 
to the JGI X. tropicalis predicted proteins provided 
the predicted protein designation number for Xenopus 
Table 1 Expression analysis for OMIM® genes that aligned to X. tropicalis genome scaffolds and X. laevis PSIDs
a 190 OMIM genes met the alignment criteria for both technologies (see Fig. 2)
b This group includes 18 OMIM® genes that were not detected by RNA‑Seq
Category Deafness Vestibular Both Total
OMIM® genes 229 53 70 352
X. tropicalis genome
 OMIM® genes that mapped to Xt genome scaffolds and met alignment criteria 204 51 67 322a
 OMIM® genes that mapped to Xt genome scaffolds, met alignment criteria,  
and met RNA‑Seq expression criteria
161 29 51 241
Affymetrix Xl‑PSIDs
 OMIM® genes that mapped to Xl‑PSID genes that met alignment criteria 154 40 40 234a
 OMIM® genes that mapped to Xl‑PSID genes that met alignment and expression criteria 96 12 18 126b
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orthologues of OMIM deafness and vestibular disorder 
genes. The protein designation number was then entered 
into the JGI Xenopus tropicalis v4.1 genome portal to 
obtain the corresponding scaffold number and coordi-
nates. The scaffold number and coordinates were then 
entered into the Alpheus® Sequence Variant detection 
software to obtain the number of RNA-Seq reads for each 
corresponding OMIM gene.
For microarray data, the TBLASTN alignments of the 
Ensembl human protein sequences to the Affymetrix X. 
laevis GeneChip® consensus sequences retrieved a list 
of microarray Xl-PSIDs whose intensity values were used 
for data analysis. The protocol and criteria for the BLAST 
alignments were identical to those previously reported 
in an open source publication; alignments that met a 
threshold E-value criterion of 10−14 were used for down-
stream analysis (H, high similarity (E ≤ 10−100); M, mod-
erate similarity (E  =   10−99 to 10−50); W, weak similarity 
(E   =   10−49 to 10−15) [17]. Some of the OMIM® genes 
mapped to multiple predicted proteins or to multiple 
Xl-PSIDs that met the detection criteria. To avoid count-
ing the same OMIM® gene twice we chose the predicted 
protein or Xl-PSID with the highest E value (Additional 
file  1). Regression analysis was undertaken to determine 
correlation between RNA-Seq reads and GCRMA value 
(microarray) for the same genes that met expression 
threshold criteria for both technologies. The regression 
was completed in the Excel data analysis tool using the 
values for orthologues that met the expression criteria for 
both technologies.
Results
Identification of X. tropicalis scaffolds for RNA‑Seq analysis
BLASTP (standalone BLAST version 2.2.27+) was used 
to align the protein sequences of deafness and vestibu-
lar disorder genes acquired from OMIM® (deafness, 
n  =  281; vestibular disorder, n  =  120) to X. tropicalis 
predicted protein sequences downloaded from JGI X. 
tropicalis genome version 4.1 [22]. This process resulted 
in 281 alignments for deafness and 120 for vestibular dis-
orders. After removal of the alignments that fell below 
the E value criteria of 10−14 or greater [17], the number 
of OMIM® genes that mapped to proteins corresponding 
to X. tropicalis scaffolds was reduced to 271 for deafness 
and 118 for vestibular disorders (Table 1; Fig. 1).
Detection of Xenopus OMIM orthologue expression 
with Illumina‑Solexa RNA‑Seq
The Alpheus® software identified RNA-Seq reads 
that aligned to X. tropicalis scaffolds for deafness and 
Fig. 1 Experimental strategy for determining the expression of OMIM® orthologues for deafness and vestibular disorder genes in the Xenopus 
inner ear transcriptome with Illumina‑Solexa (RNA‑Seq) and Affymetrix microarray methods. A comprehensive list of OMIM® genes for deafness and 
vestibular genes was manually curated and used to map OMIM® sequences to the Xl‑PSIDs on the Affymetrix GeneChip® X. laevis Genome Array, and 
to the JGI Xenopus reference genome scaffolds. Xenopus inner ear RNA was used in microarray hybridization reactions with the Affymetrix GeneChip®. 
The hybridization data were analyzed to retrieve intensity values from target Xl‑PSIDs that had met alignment criteria for OMIM® orthologues for 
deafness and vestibular disorder genes. The Alpheus® program was implemented to map inner ear RNA‑Seq reads to the JGI Xenopus reference 
genome scaffolds and the RNA‑Seq alignment data were analyzed to retrieve target scaffold regions that had met alignment criteria for OMIM® 
orthologues for deafness and vestibular disorder genes. As part of the analysis, the data were separated into three OMIM® phenotype categories: 
deafness only; vestibular disorder only; and both deafness and vestibular disorder. When expression criteria were applied to both datasets, RNA‑Seq 
methods detected expression of more OMIM® orthologues for deafness and vestibular disorder genes in the Xenopus inner ear (241) than were 
detected by microarray methods (126)
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vestibular disorders that met Illumina’s criteria of a mini-
mum of 10 reads [23]. Further analysis revealed that 222 
deafness and 86 vestibular disorder alignments for pro-
teins with corresponding X. tropicalis scaffolds met the 
detection threshold criteria for RNA-Seq expression 
(data not shown). We noted that some OMIM® genes 
aligned to the same X. tropicalis scaffold for predicted 
proteins. To avoid duplicate analysis, we analyzed RNA-
Seq expression for the OMIM® genes using the protein 
alignment with the highest E value that exceeded, or was 
equal to, the detection criteria. This procedure reduced 
the OMIM® gene lists to 212 and 80 for deafness and ves-
tibular disorders, respectively (Table 1; Fig. 1).
Detection of Xenopus OMIM® orthologue expression 
with Affymetrix microarray
TBLASTN (standalone BLAST version 2.2.27+) was 
used to align the protein sequences of the deafness and 
vestibular disorder genes acquired through OMIM® 
(deafness, n = 281; vestibular disorder, n = 120) to con-
sensus sequences from the Affymetrix X. laevis Gene-
Chip® version 2. Analysis showed 277 alignments for 
deafness and 116 for vestibular disorders. After removal 
of the alignments that fell below the E value criteria, 
the number was reduced to 194 for deafness and 80 for 
vestibular disorders. We then imposed an expression 
threshold criterion for GCRMA values of 4 or higher 
[17], thereby identifying 130 deafness and 42 vestibular 
disorders OMIM® genes that met the expression thresh-
old criterion. Some of the OMIM® genes mapped to 
multiple Xl-PSIDs that met the expression criteria. To 
avoid counting the OMIM® gene twice we chose only the 
OMIM® gene that mapped to the Xl-PSID with the high-
est E value. This procedure reduced the OMIM® detec-
tion list to 114 OMIM® deafness genes and 30 OMIM® 
vestibular disorder genes (Table 1; Fig. 1).
Comparison of RNA‑Seq and microarray detection of OMIM 
deafness and vestibular disorder orthologues
A common set of 190 Xenopus OMIM® orthologues was 
identifiable on the X. tropicalis scaffold and among the 
Xl-PSIDs on the Affymetrix Genechip (Fig. 2). When we 
compared the capacity of the two technologies to detect 
OMIM® genes, we noted that RNA-Seq detected 48 
OMIM® genes that were not detected by the microarray 
(Fig. 2). However, eleven OMIM® genes met the expres-
sion criteria for the microarray but were not detected by 
RNA-Seq. Altogether, 108 OMIM® genes were detected 
by both technologies and there were 23 OMIM® genes 
that did not meet the detection limit for either technol-
ogy (Fig. 2).
Correlation between RNA‑Seq read‑based intensity values 
and microarray Xl‑PSID intensity values for Xenopus 
OMIM® orthologues
We were interested in determining the extent of the cor-
relation between the RNA-Seq and microarray detection 
values for individual OMIM® genes whose expression 
could be evaluated by the two technologies. Figure  3 
shows a correlation plot of the log2 expression levels (in 
arbitrary units) for OMIM® genes that met the detec-
tion criteria for both technologies. A regression analysis 
established a moderate correlation between microarray 
and RNA-Seq (R = 0.49; R2 = 0.24; P < 0.5).
OMIM® genes grouped into single or dual phenotypes
Table  1 shows the number of OMIM® genes that were 
associated with both deafness and vestibular disorders as 
well those associated with only one of two disorders. The 
majority of the OMIM® genes (229) were associated only 
with deafness, 53 OMIM® genes were associated only 
with vestibular disorders, and 70 OMIM® genes were 
identified as associated with both phenotypes (Table 1). 
When comparing RNA-Seq and microarray, RNA-Seq 
detected 70  % of the deafness (only) genes, 55  % of the 
Fig. 2 Comparison of Illumina‑Solexa (RNA‑Seq) and Affymetrix 
microarray methods for detection of Xenopus orthologues for 
OMIM® deafness and vestibular disorder genes. Bar graphs compare 
detection data for 131 deafness only OMIM® genes (a), 28 vestibular 
disorder only OMIM® genes (b), 31 OMIM® genes that are associated 
with both vestibular and deafness phenotypes (c) and all 190 OMIM® 
genes (d) that met alignment criteria for both microarray and RNA‑
Seq analysis. Both technologies met expression criteria for 108 (57 %) 
of the 190 OMIM® genes. RNA‑Seq met expression criteria for 48 
(25 %) additional OMIM® genes not detected by microarray. Eleven 
(6 %) genes were detected by microarray methods only. Expression 
criteria were not met with either technology for 23 (12 %) of the 190 
Xenopus OMIM® orthologues that met alignment criteria
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vestibular disorder (only) genes, and 73  % of the dual 
phenotype genes (Table 1; Fig. 1). In contrast, the micro-
array approach detected 42  % of the deafness (only) 
genes, 23  % of the vestibular disorder (only) genes, and 
26 % of the dual phenotype genes (Table 1; Fig. 1).
Discussion
Xenopus is a well-established model organism for investi-
gations of early embryogenesis and development [18, 24, 
25]. The last decade has witnessed a rapid expansion in 
the Xenopus experimental repertoire through develop-
ment of methods for Xenopus transgenesis and genome 
editing (CRISP-R; TALEN), as well as a robust and com-
prehensive online database (Xenbase), a central national 
laboratory for production of transgenic animal stocks 
and research training (NXR), and Xenopus genome 
assemblies [25–29]. The development of algorithms, such 
as Unveiling RNA Sample Annotation (URSA), and Phy-
logenetically-Informed Annotation (PIA) are predicted 
to accelerate annotation of Xenopus genes at a faster 
and more precise rate than traditional manual annota-
tion, thereby increasing the impact of high throughput 
experiments undertaken with Xenopus [30, 31]. Here 
we have shown that a combination of data mining and 
experimental approaches can be implemented to evalu-
ate and expand the utility of Xenopus for genetic studies 
of human hereditary disorders such as those that affect 
the senses of hearing and balance. Our methods identi-
fied several hundred Xenopus OMIM® orthologues for 
deafness and vestibular disorders that met the criteria for 
RNA-Seq  (241) and microarray (126) expression (Fig. 1; 
Table 1). These findings confirm the suitability of Xeno-
pus as a model organism for genetic and functional anal-
ysis of OMIM® orthologues that are predicted to affect 
auditory and vestibular sensation in humans. Moreover, 
the identification of scaffolds for OMIM® orthologues 
on the X. tropicalis genome will accelerate genetic analy-
sis because this species offers the advantage of a shorter 
generation time, a smaller diploid genome, and a more 
detailed reference assembly than its relative, X. laevis 
[12].
Our analysis also showed that 70 OMIM® genes are 
associated with both deafness and vestibular disorders, 
as expected from the similarities between the mecha-
nosensory processes of hearing and balance and common 
features of the sensory epithelia (Table  1; Figs.  1, 2). In 
fact, diseases that affect the inner ear can disrupt both 
hearing and balance, often due to damage to the mech-
anosensory hair cells that function as cellular receptors 
for both sensory modalities [16, 32]. Mutations in these 
70 OMIM® genes potentially could cause complications 
for both hearing and balance. In contrast, 229 genes were 
associated with deafness only and 53 genes were associ-
ated with vestibular disorders only, suggesting that dam-
age to any of these genes could result in complications 
in hearing or balance but not both (Table  1; Figs.  1, 2). 
The specificity of some genes for auditory or for vestibu-
lar disorders may arise from functional and structural 
differences that are required for sensory endorgans to 
accomplish their specialized task for sense reception and 
frequency discrimination [2, 9]. For example, the spiral 
shaped cochlea is the major organ involved in the hear-
ing process, while the elongated semicircular canals, and 
sack-like utricle and sacculus with their overlying oto-
lith crystals, function specifically in the vestibular sys-
tem in humans [33]. Another explanation is that far less 
is known about the vestibular system in comparison to 
hearing; as more is learned about the vestibular system, 
we may discover that other genes that affect hearing also 
affect balance [3].
We observed that Illumina Solexa RNA-Seq methods 
detected expression of more Xenopus orthologues for 
deafness and vestibular disorder genes than the Affyme-
trix microarrays (Table 1; Figs. 1, 2). These findings are in 
agreement with studies showing that RNA-Seq technolo-
gies offer advantages over microarray technology, such as 
a greater sensitivity in the detection of gene expression, 
especially for low abundance transcripts [34–36]. Micro-
arrays are an inherently biased analysis platform because 
they are optimized to evaluate expression of the subset of 
genes represented in the probe set. However, it is note-
worthy that some deafness and vestibular disorder genes 
were detected by the microarray but not by RNA-Seq. 
This indicates that genes may be overlooked if only one 
technology is used, suggesting that the two technologies 
can complement each other and that a combination of 
both approaches can provide a more complete analysis of 
Fig. 3 Correlation plot of Affymetrix microarray and Illumina‑Solexa 
(RNA‑Seq) measurements of OMIM® gene expression. Data (log2) 
from 108 Xenopus orthologues for OMIM® deafness and vestibular 
disorder genes that met expression criteria for both technologies are 
plotted in the figure (X‑axis, microarray GCRMA intensity values; Y‑ 
axis, RNA‑Seq read based intensity value). A modest correlation was 
detected between RNA‑Seq reads and microarray intensity values in 
this analysis (R = 0.49, R2 = 0.24, P value <0.5)
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gene expression than either method alone [37–39]. It is 
intriguing that regression analysis showed moderate cor-
relation between RNA-Seq and microarray for the genes 
that met expression criteria for both technologies (Fig. 3). 
For example, some genes detected on the microarray 
were scored with high GCRMA intensity values (high 
expression), but with low corresponding RNA-Seq read 
counts, and the converse was also observed. One possi-
ble explanation for this finding is that isoforms of a gene 
differ by only a few bases. It is also possible that different 
isoforms of a gene hybridized to the same probe in the 
microarray, resulting in a higher GCRMA value [40]. On 
the other hand, low GCRMA values may be the result of 
poor hybridization of the microarray, which is a known 
limitation of this technology.
Conclusion
Here we have shown that by combining data mining and 
transcriptional profiling, it is possible to identify expres-
sion of a cadre of Xenopus orthologues for OMIM® genes 
associated with hereditary human disorders, such as 
hearing and balance. We also have identified candidate 
regions of the X. tropicalis genome that can be used as 
targets to develop Xenopus models for investigations 
of human deafness and vestibular dysfunction. Many 
of the OMIM® orthologues whose expression we have 
detected have not been the subject of detailed mechanis-
tic or genetic studies in the inner ear of Xenopus or other 
animals. We propose that our experimental approach 
(Fig.  1) can be implemented by investigators interested 
in exploring the potential of Xenopus for investigations of 
other human hereditary diseases and disorders.
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